Skip to content

Study on screening effect and economic evaluation of artificial intelligence-assisted diagnosis technology for breast cancer screening

Study on screening effect and economic evaluation of artificial intelligence-assisted diagnosis technology for breast cancer screening

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2400082733
Enrollment
Unknown
Registered
2024-04-07
Start date
2024-04-08
Completion date
Unknown
Last updated
2024-04-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast cancer

Interventions

Portable ultrasound:Portable handheld ultrasound
ABUS:Automated breast ultrasound
ABUS+AI:Artificial intelligence combined with automated breast ultrasound
Health Economics Assessment Group:None

Sponsors

Cancer Hospital, Chinese Academy of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
35 Years to 64 Years

Inclusion criteria

Inclusion criteria: Women aged 35-64 years; No visible signs of breast cancer; Ability to understand research procedures; Voluntary written informed consent

Exclusion criteria

Exclusion criteria: Pregnant, lactating women or planning to become pregnant; History of lumpectomy and breast augmentation; Those who have had a percutaneous breast piercing within one year; Previously diagnosed breast cancer patients.

Design outcomes

Primary

MeasureTime frame
Sensitivity;Specificity;Positive predictive value;Negative predictive value;AUC;

Secondary

MeasureTime frame
Detection rate of breast cancer;Number of people to be screened for each breast cancer detected;Breast X-ray examination rate;Breast pathology examination rate;Timely diagnosis rate;Incremental cost-effectiveness ratio;Direct screening cost;Reduced medical costs;Marginal incremental cost;Marginal incremental lifespan;QALYs;DALYs;Cost-effectiveness ratio;

Countries

China

Contacts

Public ContactFanghui Zhao

Cancer Hospital, Chinese Academy of Medical Sciences

zhaofangh@cicams.ac.cn+86 87788900

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026